They won't be importing ingredients from Europe like BAL and BUB so the margin is better. I agree re a loan to pay but thats a price they have to pay to expand their bussiness.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025